Skip to main content
Fig. 11 | Journal of Nanobiotechnology

Fig. 11

From: Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapies

Fig. 11

Microneedles-based transdermal drug delivery platform for the treatment of psoriasis. a Microneedle-mediated transdermal codelivery of CRISPR-Cas9–based genome editor and glucocorticoids were used for high-efficiency treatment of psoriasis. Reproduced with permission [168]. Copyright 2021, American Association for the Advancement of Science. b Characterization images of the MN patches, CP/Ad-SS-GD/Cas9 RNP nanoparticles and Dex-loaded PLGA nanoparticles; drug release of Cas9 protein and Dex from the MN patch; fluorescence images of MN patch. Reproduced with permission [168]. Copyright 2021, American Association for the Advancement of Science. c Schematic illustration of the synthesis of SKN-PMs and HCM/SKN-PMs. Reproduced with permission [216]. Copyright 2021, Elsevier. d Sketch of the MN-HCM/SKN-PM preparation process and their characterization images. Reproduced with permission [216]. Copyright 2021, Elsevier

Back to article page